Why Japan’s chemical firms still make drugs (Unknown)
In:
Chemical & Engineering News
;
98
, 11
;
24-25
;
2020
-
ISSN:
- Article (Journal) / Electronic Resource
-
Title:Why Japan’s chemical firms still make drugs
-
Additional title:C&EN
-
Published in:Chemical & Engineering News ; 98, 11 ; 24-25
-
Publisher:
- New search for: American Chemical Society
-
Place of publication:Washington, DC
-
Publication date:2020-03-23
-
ISSN:
-
Coden:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:Unknown
-
Keywords:
-
Source:
Table of contents – Volume 98, Issue 11
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Table of Contents| 2020
- 4
-
An unprecedented situation| 2020
- 5
-
In the trenches with small-firm CEOs| 2020
- 6
-
Chemistry departments deal with coronavirus closures| 2020
- 7
-
How we know disinfectants should kill the COVID-19 coronavirus| 2020
- 9
-
Automated synthesis branches out| 2020
- 9
-
Finding comets’ hidden nitrogen| 2020
- 10
-
Harnessing cells to build functional materials| 2020
- 10
-
Opening plastic packaging produces microplastics| 2020
- 10
-
Podcast: Embracing high-throughput experiments| 2020
- 11
-
PVA-based gel removes dirt from paintings| 2020
- 11
-
Fluorinated gel grabs PFAS| 2020
- 11
-
Quarantines cause rapid drop in air pollution| 2020
- 12
-
COVID-19 coronavirus weighs on economy, chemicals| 2020
- 12
-
Stepping up to the sanitizer shortage| 2020
- 13
-
IL-6 blockers tested against COVID-19| 2020
- 13
-
BioNTech joins the coronavirus vaccine race| 2020
- 14
-
Huntsman to buy resin maker| 2020
- 14
-
New Zealand invests in wind-powered H2| 2020
- 14
-
Toray opens foam innovation center| 2020
- 14
-
Quikrete, Oak Ridge want to print concrete| 2020
- 14
-
DSM will make biobased Dyneema| 2020
- 14
-
BASF, Clariant delay annual meetings| 2020
- 14
-
DuPont, Irish firm eye microbes for babies| 2020
- 15
-
Evonik rolls out nonanimal collagen| 2020
- 15
-
Fake-meat firms raise funds for growth| 2020
- 15
-
AGC to bolster drug services with MolMed| 2020
- 15
-
Business Roundup| 2020
- 15
-
Antibiotic maker Tetraphase goes cheap| 2020
- 15
-
ZBiotics raises funds for hangover probiotic| 2020
- 16
-
Air-quality improvements boosted California ag| 2020
- 17
-
Leaks of CFCs threaten ozone layer recovery and climate| 2020
- 17
-
EPA overhauls pesticide biological evaluations| 2020
- 18
-
Crackdown on China exchanges| 2020
- 21
-
Getting the 1,4-dioxane out| 2020
- 24
-
Why Japan’s chemical firms still make drugs| 2020
- 26
-
Ilham Kadri is reshaping Solvay| 2020
- 28
-
Your new job sucks. Now what?| 2020
- 29
-
Periodic Graphics: The elements of fertilizers| 2020
- 31
-
An intense love of science| 2020
- 34
-
Ads| 2020
- 34
-
Classifieds| 2020
- 34
-
Masthead| 2020
- 37
-
The road less traveled: For love of detection, discovery, and all things radical in nature| 2020
- 43
-
Preparing a blueprint for advancing your professional development| 2020
- 44
-
ACS Scholar alumnus: Bart Bartlett| 2020
- 45
-
John Stelter wins chemical technician award| 2020
- 45
-
Nominations sought for Norris teaching award| 2020
- 45
-
CHAS presents 2020 awards| 2020
- 45
-
Carolyn Bertozzi awarded 2020 Solvay Prize| 2020
- 48
-
A chemist enters a popular TV baking competition, and a cat food discovery| 2020